Statewide initiative improves opioid use disorder care for pregnant patients
January 29th 2025The Mothers and Newborns affected by Opioids - Obstetric initiative significantly increased screening, treatment access, and naloxone counseling for pregnant patients with opioid use disorder, enhancing care and reducing racial disparities.
New guidelines show better outcomes for managing hematological malignancies in pregnancy
January 24th 2025Discover updated strategies for treating leukemia and lymphomas during pregnancy, emphasizing delayed delivery, chemotherapy safety, and multidisciplinary care for optimal maternal and fetal health.
FDA grants 510(k) clearance to cobas liat STI multiplex assay panels
Published: January 22nd 2025 | Updated: January 22nd 2025The new panels, leveraging rapid polymerase chain reaction technology, allow point of care sexually transmitted infection diagnosis in 20 minutes, enhancing targeted treatment and reducing follow-up losses.
Contraceptive trends indicate reduced hormone use and rise in natural methods
January 21st 2025A recent study reveals shifts in contraceptive preferences, highlighting increased use of natural family planning, declining reliance on hormonal methods, and the need for better access to reliable information.
Timely surveillance reported in under half of HPV-positive patients
January 20th 2025A recent study highlights gaps in cervical cancer screening compliance, with fewer than 50% of human papillomavirus-positive, negative for intraepithelial lesion or malignancy patients receiving recommended follow-up testing within the guideline time frame.
Radon exposure linked to increased risk of gestational diabetes
January 20th 2025A new study reveals that high radon exposure, especially when combined with smoking or air pollution, significantly raises the risk of gestational diabetes, highlighting the impact of environmental factors on maternal health.
USPSTF recommends osteoporosis screening for senior women to prevent fractures
January 20th 2025The US Preventive Services Task Force emphasizes screening for osteoporosis in women aged 65 years and older and at-risk postmenopausal women aged under 65 years, citing moderate benefits in fracture prevention.